IBREXAFUNGERP | IBREXAFUNGERP | ATC J02AX07
ANTIINFECTIVES A TRITERPENOID ANTIFUNGAL TREATMENT OF VULVOVAGINAL CANDIDIASIS (VVC) INHIBITS GLUCAN SYNTHASE | ORAL | Cmax 861 NANOMOLAR Tmax 5 HOUR VD 600 LITER PPB 99 PERCENT HT 20 HOUR | GLUCAN SYNTHASE | Beta-1,3-glucan synthase catalytic subunit 1 UNIPROT O13428 GSC1 -- 1,3-Beta-D-glucan-UDP glucosyltransferase UNIPROT Q6FTN8 FKS1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |